Curve Therapeutics Co-Founder and CSO Professor Ali Tavassoli awarded the Royal Society of Chemistry's Interdisciplinary Prize

Curve Therapeutics United Kingdom United States of America England

Awarded in recognition of excellence in research and innovation and contribution to scientific progress Reflects the revolutionary potential of Curve's gene-encoded Microcycle® platform to unlock the therapeutic potential of intracellular targetsView original content:https://www.prnewswire.co.uk/news-releases/curve-therapeutics-co-founder-and-cso-professor-ali-tavassoli-awarded-the-royal-society-of-chemistrys-interdisciplinary-prize-302490717.html